Regional state Autonomous healthcare institution "Sanatorium "Beautiful" carries out the second phase of rehabilitation on the profile and services:
profile Name | Name of service |
---|---|
cardiac rehabilitation | Services for the rehabilitation of the patient undergoing surgery on the heart and great vessels |
Services for the rehabilitation of the patient after acute myocardial infarction | |
Rehabilitation for other somatic diseases | rehabilitation Services to patients with diseases of the cardiovascular system |
the second phase of rehabilitation patients are sent as a part of rehabilitation potential and favorable rehabilitation prognosis: in the early recovery period of the disease, in the late rehabilitation period, in the period of the residual phenomena of the disease during the chronic, diseases out of aggravation.
the Selection and assignment of patients to rehabilitation is carried out by the Commission, which was established in hospitals.
the condition of having a medical rehabilitation assistance is available:
the waiting Time for medical care – up to 6 days.
the Indicators of accessibility and quality of medical care in rehabilitation:
feature Name | Unit of measurement | Target value 2018 |
---|---|---|
the Number of beds with cardiac profile | bunk | 60 |
Average duration of treatment | days | 15,3 |
Number of patients | people | 1200 |
the Number of days in hospital on 1,000 people | patient days | 18,3 |
hospitalization | man on 1,000 people | 1,2 |
Mode of operation of enterprises — hour, admission of patients to the Department of rehabilitation is carried out in the working days from 8:00 to 16:00.
In accordance with the Decree of the RF Government of December 10, 2018 N 2738-p approved the list of vital and essential medicines and medical products necessary for rendering of emergency and inpatient care, medical aid in day hospitals of all types.
Recall that the limit selling prices of manufacturers for these drugs are subject to state registration. Regional bodies set limits on the amounts of wholesale and retail extra charges to actual cost prices of manufacturers for these drugs.